Fig. 2: Evaluation of clinical status of piglets challenged with O55 E. coli incubated with various SIgA forms. | Mucosal Immunology

Fig. 2: Evaluation of clinical status of piglets challenged with O55 E. coli incubated with various SIgA forms.

From: Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets

Fig. 2

Germ-free piglets (five piglets per group) at day 5 after delivery were challenged orally with E. coli O55 preincubated with SIgA forms or PBS. Individual groups of five piglets were labeled based on E. coli O55 pretreatment. Germ-free–E. coli-unexposed piglets. 35 h after challenge clinical status was evaluated as weighted means of scaled parameters: temperature, drink volume, stool, and interest as specified in Table 2 and Supplementary Table 1. Means ± SD are provided. P values were calculated using Kruskal-Wallis test with Dunn-Bonferroni post-hoc test. *p < 0.05, **p < 0.01, ***p < 0.001.

Back to article page